Used by healthcare professionals to provide an easy and convenient point-of-care testing of Influenza A or B virus in a symptomatic patient. Meets the new FDA reclassification criteria and CLIA-waived, specimen needed for testing can be collected directly through anterior nasal or nasopharyngeal swabbing. Accurate and fast results will be shown on the test device in as fast as 10-15 minutes and promotes efficiency and precision allowing proper differentiation of Flu A and B infection.